SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-14-002279
Filing Date
2014-11-19
Accepted
2014-11-19 16:42:43
Documents
1
Group Members
AISLING CAPITAL LLCANDREW SCHIFFDENNIS PURCELLPERSEUS-SOROS BIOPHARMACEUTICAL FUND LPPERSEUS-SOROS PARTNERS LLCSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh1401266_13da1-ambit.htm SC 13D/A 186152
  Complete submission text file 0000950142-14-002279.txt   187819
Mailing Address 888 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address ARMY & NAVY CLUB BLDG 1627 I ST NW STE 610 WASHINGTON DC 20006 (212) 651-6389
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP (Filed by) CIK: 0001111408 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address 11080 ROSELLE STREET SAN DIEGO CA 92121 8583342100
AMBIT BIOSCIENCES CORP (Subject) CIK: 0001131543 (see all company filings)

IRS No.: 330909648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87467 | Film No.: 141236008
SIC: 2834 Pharmaceutical Preparations